EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Snakebites in Cameroon: Tolerance of a Snake Antivenom (Inoserp™ PAN-AFRICA) in Africa in Real-Life Conditions

David Benhammou, Jean-Philippe Chippaux iD, Rodrigue Ntone, Yoann Madec, Pierre Amta, Gaëlle Noel, Fai Njuwa Karl iD, Anaïs Perilhou, Lucrece Matchim iD, Marie Sanchez, Mark Ndifon, Pedro Clauteaux und 4 weitere

Toxins · 2024

DOI: 10.3390/toxins16040165 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Toxins, 2024. Verfasst von David Benhammou und 15 weiteren Autor:innen. Beteiligte Einrichtung: Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris Cité University, F-75015 Paris, France. Hauptthemen laut MEDLINE: Snake Bites, Antivenins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut Pasteur, Inosan Biopharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Snakebite envenomation (SBE) is a public health issue in sub-Saharan countries. Antivenom is the only etiological treatment. Excellent tolerance is essential in managing SBE successfully. This study aimed to evaluate tolerance of InoserpTM PAN-AFRICA (IPA). It was conducted on fourteen sites across Cameroon. IPA was administered intravenously and repeated at the same dose every two hours if needed. Early and late tolerance was assessed by the onset of clinical signs within two hours and at a visit two weeks or more after the first IPA administration, respectively. Over 20 months, 447 patients presenting with a snakebite were included. One dose of IPA was administered to 361 patients and repeated at least once in 106 patients. No significant difference was shown between the proportion of adverse events in patients who received IPA (266/361, 73.7%) and those who did not (69/85, 81.2%) (p = 0.95). Adverse reactions, probably attributable to IPA, were identified in four (1.1%) patients, including one severe (angioedema) and three mild. All these reactions resolved favorably. None of the serious adverse events observed in twelve patients were attributed to IPA. No signs of late intolerance were observed in 302 patients. Tolerance appears to be satisfactory. The availability of effective and well-tolerated antivenoms would reduce the duration of treatment and prevent most disabilities and/or deaths.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Snake BitesAntiveninsHumansMaleCameroonFemaleAdultMiddle AgedAdolescentYoung AdultChildAgedChild, PreschoolAged, 80 and overSnake VenomsAnimalsDrug Tolerance

Stichwörter der Autor:innen

Cameroonantivenomenvenomationsnakebitesub-Saharan Africatolerancetreatment

Substanzen

AntiveninsSnake Venoms

Autor:innen und Institutionen

  • Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris Cité University, F-75015 Paris, France.
  • MERIT Unit, Institut de Recherche pour le Développement, Paris Cité University, F-75006 Paris, France.
  • Epicentre Yaounde, Yaounde BP 12069, Cameroon.
  • Tokombere Hospital, Tokombere, Mora BP 74, Cameroon.
  • Institut Pasteur, Translational Research Center, Paris Cité University, F-75015 Paris, France.
  • Institut Pasteur, Clinical Research Coordination Center, Paris Cité University, F-75015 Paris, France.

ORCID-Profile: Jean-Philippe Chippaux, Fai Njuwa Karl, Lucrece Matchim, Fabien Taieb

Förderung

  • Institut Pasteur
  • Inosan Biopharma

Zitieren

APA

Benhammou, D., Chippaux, J. P., Ntone, R., Madec, Y., Amta, P., Noel, G., Karl, F. N., Perilhou, A., Matchim, L., Sanchez, M., Ndifon, M., Clauteaux, P., Eteki, L., Boum, Y., Nkwescheu, A. S., & Taieb, F. (2024). Snakebites in Cameroon: Tolerance of a Snake Antivenom (Inoserp™ PAN-AFRICA) in Africa in Real-Life Conditions. Toxins. https://doi.org/10.3390/toxins16040165

Vancouver

Benhammou D, Chippaux JP, Ntone R, Madec Y, Amta P, Noel G, et al. Snakebites in Cameroon: Tolerance of a Snake Antivenom (Inoserp™ PAN-AFRICA) in Africa in Real-Life Conditions. Toxins. 2024. doi:10.3390/toxins16040165

BibTeX
@article{Benhammou2024,
  author = {Benhammou, David and Chippaux, Jean-Philippe and Ntone, Rodrigue and Madec, Yoann and Amta, Pierre and Noel, Gaëlle and Karl, Fai Njuwa and Perilhou, Anaïs and Matchim, Lucrece and Sanchez, Marie and Ndifon, Mark and Clauteaux, Pedro and Eteki, Lucrèce and Boum, Yap and Nkwescheu, Armand Seraphin and Taieb, Fabien},
  title = {Snakebites in Cameroon: Tolerance of a Snake Antivenom (Inoserp™ PAN-AFRICA) in Africa in Real-Life Conditions},
  journal = {Toxins},
  year = {2024},
  doi = {10.3390/toxins16040165}
}
Kostenlos starten →